The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS

Eur J Neurol. 2010 May;17(5):754-6. doi: 10.1111/j.1468-1331.2009.02859.x. Epub 2009 Nov 13.

Abstract

Background and purpose: Mutations in fused in sarcoma (FUS) were recently identified as a cause of familial amyotrophic lateral sclerosis (ALS). The frequency of occurrence of mutations in FUS in sets of patients with familial ALS remains to be established.

Methods: We sequenced the FUS gene in a cohort of patients with familial ALS seen at the neuromuscular clinic in Leuven. A total of 28 patients with SOD1-negative ALS from 22 families were analyzed.

Results: We identified a R521H mutation in 4 patients, belonging to a kindred of dominantly inherited classical ALS. The mutation segregated with disease. Mutations in FUS were observed in 2.9% of ALS pedigrees in our cohort.

Conclusions: These results show that mutations in FUS are also a significant cause of familial ALS in Belgium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Amyotrophic Lateral Sclerosis / epidemiology
  • Amyotrophic Lateral Sclerosis / genetics*
  • Belgium
  • Cohort Studies
  • Disease Progression
  • Female
  • Gene Frequency / genetics
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Pedigree
  • RNA-Binding Protein FUS / genetics*

Substances

  • Genetic Markers
  • RNA-Binding Protein FUS